Eric Kelsic

Company: Dyno Therapeutics

Job title: Chief Executive Officer & Co-Founder

Seminars:

Machine Learning to Identify the Next Generation of AAV 11:30 am

What key benefits does machine learning hold over traditional AAV capsid engineering methods? Multi-property optimization to both increase transduction efficacy and reduce the immune response Comparing model evaluation results between machine-guided sequences and traditional methods. Approaches to funnelling through capsid libraries to identify top-performing candidatesRead more

day: Day 1 Track A AM